Kbc Group Nv Legend Biotech Corp Transaction History
Kbc Group Nv
- $33.1 Billion
- Q3 2024
A detailed history of Kbc Group Nv transactions in Legend Biotech Corp stock. As of the latest transaction made, Kbc Group Nv holds 13,144 shares of LEGN stock, worth $527,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,144
Previous 13,144
-0.0%
Holding current value
$527,600
Previous $582,000
10.14%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$448 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$301 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$266 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$230 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$202 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.72B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...